Identification of biomarkers of the rate of ageing

Identification of biomarkers of the rate of ageing - Identification of biomarkers of the rate of ageing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30039

Enrollment

900

Registered

2006-08-11

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

we onderzoeken geen ziekten, maar contrasteren twee groepen mensen met een verschil in levensverwachting not applicable

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participant in the first phase of the project (2002-2005).

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
All parameters that will be used to contrast both study group will be obtained from the measurements we employ • food frequency questionnaire • digital photograph of face • skin surface replica • blood sampling • grip strength • bodily measurements • urine collection • Bioelectrical Impedance Analysis (BIA) 300 subjects: • Oral Glucose Tolerance Test (OGTT) • Dual Energy X-ray Absorptiometry (DEXA)-scan • 24 hr food recall questionnaire • 24 hr urine collection the other 600 subjects: • skin biopsy • blood sampling for peripheral blood monocytes (PBMCs) isolation	—

Measure

Time frame

All parameters that will be used to contrast both study group will be obtained from the measurements we employ • food frequency questionnaire • digital photograph of face • skin surface replica • blood sampling • grip strength • bodily measurements • urine collection • Bioelectrical Impedance Analysis (BIA) 300 subjects: • Oral Glucose Tolerance Test (OGTT) • Dual Energy X-ray Absorptiometry (DEXA)-scan • 24 hr food recall questionnaire • 24 hr urine collection the other 600 subjects: • skin biopsy • blood sampling for peripheral blood monocytes (PBMCs) isolation

—

Countries

Netherlands

Outcome results